Cefepime/Sulbactam — A New Innovative Antibiotic for In-Hospital Treatment of Severe Infections and the Implementation of Carbapenem-Replacement Strategy to Contain Antibiotic Resistance
Cefepime/sulbactam is a combined antibiotic consisting of the 4 th generation cephalosporin cefepime and the beta-lactamase inhibitor sulbactam in 1:1 ratio. Cefepime/sulbactam antibiotic was developed in Russia in 2006, it had passed preclinical and clinical studies, was approved for medical use, a...
Saved in:
| Main Authors: | S. V. Yakovlev, M. P. Suvorova, A. O. Bykov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC "Publishing House OKI"
2021-06-01
|
| Series: | Антибиотики и Химиотерапия |
| Subjects: | |
| Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/807 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cefotaxime/Sulbactam: an Important Addition to the Arsenal of Inhibitor-Protected Beta-Lactam Antibiotics
by: S. V. Yakovlev, et al.
Published: (2020-05-01) -
An Open-Label, Multicenter, Observational Study of The Effectiveness of The Cefepime/Sulbactam Antibiotic (Maxictam<sup>®</sup>-AF) In Patients With Intra Abdominal Infection, Nosocomial Pneumonia or Ventilator-Associated Pneumonia (Study MAXI-2019)
by: S. V. Yakovlev, et al.
Published: (2021-02-01) -
Beta-lactam antibiotics as reserve medications for the treatment of drug-resistant tuberculosis
by: G. N. Mozhokina, et al.
Published: (2021-08-01) -
New Insights on the Carbapenem-resistant Gram Negative-associated-Infections: Challenges and Opportunities
by: Samar S. Mabrouk, et al.
Published: (2023-06-01) -
Common Genotypes of Carbapenamase Observed in Members of the Enterobacteriaceae in Tertiary Care Hospital in South India
by: B. Appalaraju, et al.
Published: (2025-06-01)